FDA Authorizes Pfizer Pill To Treat COVID-19
This Wednesday, the FDA announced that it has authorized Pfizer’s antiviral pills to treat COVID-19 for emergency use, which allows limited use of the drug in Americans as young as 12 who are at “high risk for progression to severe COVID-19,” according to CNN.
RELATED: BREAKING NEWS: Pfizer Has Announced A Pill To Treat COVID-19 — Would You Take This?
The Food and Drug Administration issued emergency authorization for Pfizer’s Paxlovid, a pill that is available by prescription only. It was noted that it should be initiated as soon as possible after a diagnosis of COVID-19 and within five days of symptom onset.
“Today’s authorization introduces the first treatment for COVID-19 that is in the form of a pill that is taken orally — a major step forward in the fight against this global pandemic,’ said Dr. Patrizia Cavazzoni director of the FDA’s Center for Drug Evaluation and Research in a statement.
This is a long-awaited milestone as this comes as U.S. cases, hospitalizations, and deaths rise and health officials warn of a major wave of new infections from the Omicron variant that could overwhelm hospitals.
“This authorization provides a new tool to combat COVID-19 at a crucial time in the pandemic as new variants emerge and promises to make antiviral treatment more accessible to patients who are at high risk for progression to severe COVID-19.”
Press Play Below For More:
RELATED: British Researchers Find Mixing Pfizer and Moderna Vaccines Gives A Better Immune System